Cynthia Xue, Lorenzo Segabinazzi, Alexis Hall, Tarisai Brighton Dzikiti, Hilari French, Robert Gilbert
Article Summary
Clinically, flunixin meglumine and phenylbutazone are preferentially selected for the treatment of visceral and musculoskeletal pain, respectively, in horses. In donkeys, there is no information to support or refute this conventional conjecture. The aim of this retrospective cohort study was to compare postoperative outcomes in a group of jennies treated with intravenous flunixin meglumine or oral phenylbutazone following unilateral ovariectomies by standing left flank laparotomy.
Data from medical records of 14 ovariectomised jennies (case details, weight, non-steroidal anti-inflammatory drug [NSAID] protocol, surgery duration, operative sequence, anaesthesia protocol, physical examination findings and outcomes) were collected. From collated data, postoperative adverse events were defined as fever, tachycardia, tachypnoea, inappetence, altered mentation, abnormal oral mucous membranes, bruxism, colic, incisional complications (i.e., drainage, oedema, peri-incisional emphysema and pain) and non-survival, then further divided into occurrence during the early (≤24 h) or late (>24 h) postoperative period for data analysis using R software. Individual adverse events were compared between groups (phenylbutazone vs. flunixin meglumine) and moments (early vs. late).
Phenylbutazone treatment (2.2mgkg IV pre-op, then 2.2mgkg PO BID for 3 days post-op) (8/14) was associated with significantly (odds ratio, 95% confidence interval) more total (2.93, 1.97–4.36), early (3.01, 1.87–4.84) and late (2.69, 1.28–5.63) adverse events than flunixin meglumine treatment (1.1mgkg IV pre-op and 1.1mgkg IV BID for 3 days post-op) (6/14). Tachycardia (37.83, 2.21–646.66), tachypnoea (0.29, 0.13–0.66), altered mentation (2.78, 1.01–7.67), altered mucous membranes (18.38, 1.04–325.23), incisional oedema (44.33, 2.60–754.5) and incisional pain (47.78, 2.81–811.61) were significantly different between groups. Early adverse events significantly different between groups included tachycardia (50.2, 2.9–877.0), altered mentation (3.33, 1.08–10.29) and incisional pain (21.0, 1.2–374.5), with late adverse events being tachypnoea (0.07, 0.01–0.62), incisional oedema (32.92, 1.85–584.28) and incisional pain (28.92, 1.62–515.68). Colic (2/8) and non-survival (1/8) were rare events that only occurred in the phenylbutazone cohort and could not be further evaluated for differences.
Bottom line: When surgery length, operative sequence and anaesthetic protocol were controlled for, PBZ-treated donkeys were more likely to show abnormal physiologic parameters, changes in behaviour and incisional discomfort compared with FM-treated jennies. Therefore, IV FM may be the more appropriate NSAID for abdominal surgery in donkeys.
Read the article